The Foundation supports research across basic, translational and clinical science to speed breakthroughs that can lead to the creation of new treatments and a better quality of life for people with Parkinson's disease.
Search or browse funded studies
Previously funded studies appear chronologically, with the most recent appearing first.
-
Research Grant, 2015Selective mGluR3 Positive Allosteric Modulators as Neuroprotective Agents for Parkinson's Disease Supplement
Study Rationale:
mGluR3 is a novel target leading to neuroprotection through production of neurotrophic factors. We have recently demonstrated that selective mGluR3 positive... -
Research Grant, 2015Pre-clinical Evaluation of Neuroprotective Small Molecule Erythropoietin Receptor Agonists in the Treatment of Parkinson’s Disease Supplement
Study Rationale:
STATegics has discovered small molecules that selectively activate the tissue-protective erythropoietin (EPO) receptor, but not the EPO receptor that plays a role in... -
Therapeutic Pipeline Program, 2015GAITPARK_ATLAS: Finding New Targets to Treat Gait and Balance Disorders in Parkinson’s Disease
Study Rationale:
Gait and balance disorders are the primary motor disability in advanced Parkinson’s disease (PD). These disorders arise in part due to dysfunction of the lateral... -
Research Grant Supplement, 2015Parc (a Parkin-related E3 ligase): Functions in Neuronal Survival and Parkinson’s Disease Supplement
Promising Outcomes of Original Grant:
Our research had identified a Parkin-related protein, called Parc, to be important for neuronal survival in situations of mitochondrial injury. Specifically, we... -
Improved Biomarkers and Clinical Outcome Measures, 2015Measuring Altered White Blood Cell Functionality as a Biomarker of Parkinson’s Disease
Study Rationale:
White blood cells from people with Parkinson’s disease (PD) patients appear to differ from those of control individuals in that there are differences in the set of genes that are... -
Research Grant Supplement, 2015The Influence of Bacterial Amyloid on Alpha-synuclein Misfolding in a Pre-clinical Model Supplement
Promising Outcomes of Original Grant:
We hypothesized that that deposits of the Parkinson’s disease-associated protein alpha-synuclein in gut and brain neurons are caused by exposure to proteins of...
Apply for a Grant
Our funding programs support basic, translational and clinical research from academia and industry.